Merck & Co., Inc. (NYSE:MRK) Price Target Raised to $145.00
Merck & Co., Inc. (NYSE:MRK – Free Report) had its target price increased by UBS Group from $130.00 to $145.00 in a research report sent to investors on Monday,Benzinga reports. They currently have a buy rating on the stock. Other research analysts also recently issued reports about the company. Weiss Ratings restated a “hold (c)” […]
16 Apr 07:46 · The Markets Daily